valproic acid has been researched along with Bone Diseases, Metabolic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pitetzis, DA; Spilioti, MG; Yavropoulou, MP; Yovos, JG | 1 |
| Ayus, JC; Moritz, ML; Patel, M | 1 |
| Baek, JH; Eun, BL; Kim, GH; Kim, MK; Seo, YH | 1 |
| Kerling, F; Merschin, D; Stangl, R; Winterholler, M | 1 |
| Antoniou, A; Armeni, E; Boufidou, F; Evangelopoulos, EM; Lambrinoudaki, I; Triantafyllou, N; Tsivgoulis, G | 1 |
| Androphy, EJ; Fuller, HR; Lam, le T; Man, NT; Morris, GE; Shamanin, VA | 1 |
| Asher, JM; Baram, V; McGuire, JM | 1 |
| Celtik, C; Karaca, H; Karasalihoğlu, S; Kaya, M; Oner, N; Tütüncüler, F | 1 |
| Choi, KG; Chung, HW; Kim, SH; Lee, HW; Lee, JW | 1 |
| McMahon, DJ; Morrell, MJ; Pack, AM; Randall, A; Shane, E | 1 |
| Atkinson, SA; Guo, CY; Ronen, GM | 1 |
| Hiraoka, M; Kimura, K; Mayumi, M; Miura, M; Ohshima, Y; Shigematsu, Y; Todoroki, Y; Tsukahara, H; Tsukahara, Y | 1 |
| Takeno, Y | 1 |
1 review(s) available for valproic acid and Bone Diseases, Metabolic
| Article | Year |
|---|---|
The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited.
Topics: Animals; Anticonvulsants; Bone and Bones; Bone Diseases, Metabolic; Cells, Cultured; Humans; Valproic Acid; Vitamin D | 2017 |
1 trial(s) available for valproic acid and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Bone mineral metabolism changes in epileptic children receiving valproic acid.
Topics: Absorptiometry, Photon; Adolescent; Alkaline Phosphatase; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Calcium; Child; Child, Preschool; Diet; Epilepsy; Femur; Humans; Lumbar Vertebrae; Osteocalcin; Valproic Acid | 2004 |
11 other study(ies) available for valproic acid and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Fragility fractures and reversible osteopaenia due to chronic hyponatraemia in an adolescent male.
Topics: Absorptiometry, Photon; Adolescent; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Epilepsy; Fracture Fixation, Internal; Hip Fractures; Humans; Hyponatremia; Male; Osteoporotic Fractures; Risk Factors; Treatment Outcome; Valproic Acid | 2019 |
Vitamin D levels in children and adolescents with antiepileptic drug treatment.
Topics: Adolescent; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Carbamazepine; Child; Child, Preschool; Developmental Disabilities; Epilepsy; Female; Humans; Intellectual Disability; Male; Osteoporosis; Oxcarbazepine; Retrospective Studies; Valproic Acid; Vitamin D; Vitamin D Deficiency | 2014 |
[Epilepsy and transverse sternum fractures: sternum fractures in drug-induced osteopenia].
Topics: Adult; Anticonvulsants; Bone Diseases, Metabolic; Bone Plates; Epilepsy; Female; Fracture Fixation, Internal; Fractures, Bone; Humans; Sternum; Treatment Outcome; Valproic Acid | 2014 |
Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
Topics: Absorptiometry, Photon; Adult; Anticonvulsants; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Chronic Disease; Cross-Sectional Studies; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Osteoporosis; Time; Time Factors; Valproic Acid; Young Adult | 2010 |
Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells.
Topics: Bone Diseases, Metabolic; Chromatography, Liquid; Collagen; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Histone Deacetylase Inhibitors; Humans; Immunohistochemistry; Mass Spectrometry; Muscular Atrophy, Spinal; Osteonectin; Proteomics; Skin; Valproic Acid | 2010 |
Osteopenia associated with divalproex sodium.
Topics: Adult; Bone Diseases, Metabolic; Humans; Male; Valproic Acid | 2004 |
A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcitriol; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Longitudinal Studies; Male; Middle Aged; Parathyroid Hormone; Triazines; Valproic Acid; Vitamin D | 2007 |
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Calcium, Dietary; Carbamazepine; Collagen Type I; Epilepsy; Female; Femur; Humans; Lamotrigine; Life Style; Lumbar Vertebrae; Minerals; Parathyroid Hormone; Peptides; Phenytoin; Surveys and Questionnaires; Triazines; Valproic Acid; Vitamin D | 2008 |
Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Bone and Bones; Bone Density; Bone Diseases, Developmental; Bone Diseases, Metabolic; Calcium, Dietary; Child; Child Development; Child, Preschool; Diet; Epilepsy; Female; Growth; Humans; Lamotrigine; Male; Osteocalcin; Physical Exertion; Triazines; Valproic Acid; Vitamin D | 2001 |
Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Topics: Absorptiometry, Photon; Adolescent; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcium, Dietary; Carbamazepine; Child; Epilepsy; Female; Humans; Lumbar Vertebrae; Male; Receptors, Calcitriol; Sex Factors; Valproic Acid | 2002 |
[Evaluation of bone atrophy by microdensitometry and effect of active vitamin D3 (1 alpha-OH-D3) administration in patients receiving anticonvulsants].
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Anticonvulsants; Atrophy; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Child; Child, Preschool; Female; Humans; Hydroxycholecalciferols; Male; Metacarpus; Middle Aged; Valproic Acid | 1989 |